An observational study in Tonsil; Injury and Surgical Blood Loss, sponsored by Dr. Abdul Mohsen Ibrahim Al-Turki Clinic. Completed. Open to participants aged Up to 12 Years. Per ClinicalTrials.gov, last updated 2019-06-13.
Sponsored by Dr. Abdul Mohsen Ibrahim Al-Turki Clinic · Observational
Tonsillectomy is one of the commonest procedures performed in otolaryngology and one of its major complications is post-tonsillectomy bleeding.
The goal of this study was to assess the effectiveness of Surgicel without bipolar cautery in achieving primary hemostasis in tonsillectomy. The patient that were enrolled in this retrospective study were patients who underwent tonsillectomy and achieved hemostasis either by Surgicel (group A) or bipolar cautery (group B). Our results showed that there was no statistical significant difference between the two techniques in terms of post-operative bleeding events.
Tonsillectomy is one of the commonest procedures performed in otolaryngology and one of its major complications is post-tonsillectomy bleeding.
The goal of this study was to assess the effectiveness of Surgicel without bipolar cautery in achieving primary hemostasis in tonsillectomy.
The study was a retrospective cohort in three tertiary care centers in xxxx, from January 2016 to August 2018. All patients underwent at least tonsillectomy, with a proportion undergoing additional adenoidectomy, myringotomy, or tube insertion as indicated, were enrolled in the study. Patients were stratified to 2 groups according to the surgeons preference for the hemostasis technique, one was subjected to cold dissection tonsillectomy and achieved hemostasis via the application of Surgicel to the surgical site, and the other underwent cold dissection tonsillectomy and attained hemostasis through bipolar cautery.
218 studies on the registry are indexed under Blood Loss, Surgical; 39 are open to participants now.
This study's enrollment of 203 is above the median of 154 across 49 observational studies indexed under Blood Loss, Surgical.
Browse Blood Loss, Surgical studies →This is the only study on the registry with Dr. Abdul Mohsen Ibrahim Al-Turki Clinic as lead sponsor.
Counted across the registry records on this site, refreshed daily.
any patient under the age of 12 who underwent tonsillectomy due to either recurrent tonsillitis or OSA by the 3 consultant otolaryngology surgeon authors in the study
Exclusion Criteria:
a retrospective cohort study. Two groups were assigned, the first under the care of the author \[AA\], in which patients of his group underwent cold dissection tonsillectomy and achieved hemostasis via surgicel (without bipolar cautery). While group B patients (consisted of 2 surgeons) underwent cold dissection tonsillectomy and attained hemostasis with bipolar cautery. The main outcome that was pursued was postoperative tonsillectomy bleeding
a retrospective cohort study. Two groups were assigned, the first under the care of the author \[AA\], in which patients of his group underwent cold dissection tonsillectomy and achieved hemostasis via surgicel (without bipolar cautery). While group B patients (consisted of 2 surgeons) underwent cold dissection tonsillectomy and attained hemostasis with bipolar cautery. The main outcome that was pursued was postoperative tonsillectomy bleeding
Primary Post-operative tonsillectomy bleeding
Bleeding due to the surgical procedure within 24 hours from the surgery
Time frame: 24 hours post-op
Secondary Post-operative Tonsillectomy bleeding
Bleeding due to the surgical procedure after 24 hours from the surgery
Time frame: after 24 hours
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.